Valuation: BioAdaptives, Inc.

Market Cap 295K 256K 242K 219K 411K 28.34M 414K 2.89M 1.11M 14.37M 1.11M 1.08M 45.82M P/E 2024
-0.55x
P/E 2025 -0.14x
Enterprise Value 521K 452K 427K 387K 726K 50.01M 731K 5.1M 1.96M 25.36M 1.96M 1.92M 80.87M EV / Sales 2024
55.1x
EV / Sales 2025 26.9x
Free-Float
5.04%
Yield 2024 *
-
Yield 2025 -
1 week+25.00%
Current month+15.38%
1 month-8.26%
3 months-50.00%
6 months-88.46%
Current year-93.21%
1 week 0
Extreme 0.0012
0
1 month 0
Extreme 0.001
0
Current year 0
Extreme 0.0008
0.03
1 year 0
Extreme 0.0008
0.07
3 years 0
Extreme 0.0008
0.81
5 years 0
Extreme 0.0008
7.28
10 years 0
Extreme 0.0008
108
Manager TitleAgeSince
Chief Executive Officer 55 2024-05-20
Investor Relations Contact - -
Corporate Officer/Principal 63 -
Director TitleAgeSince
Director/Board Member 53 2024-05-29
Chairman 55 2024-05-20
Director/Board Member 70 2025-02-02
Date Insider Type Main position Quantity % Market Cap. Importance
2/15/25 Buy

Director

1 0.0000%
11/22/24 Buy

Director

125,000 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+25.00%-95.00%-99.74% 295K
-0.63%+0.38%+8.52%+63.61% 12.22B
-0.83%-4.39%-13.28%+224.31% 8.95B
-0.54%-6.29%-23.64%-51.34% 2.3B
-1.77%-5.23%-16.11%-10.63% 1.45B
-0.20%-0.22%+22.85%+76.26% 1.35B
-1.00%-4.02%+28.42%-18.23% 1.25B
-0.54%-6.54%-74.23%-77.51% 1.06B
+5.07%-3.19%-42.83% - 1.09B
-1.11%-8.64%-62.39%-70.97% 870M
Average -0.16%+0.04%-26.77%+3.97% 3.06B
Weighted average by Cap. -0.54%-0.52%-6.74%+87.81%

Financials

2024 2025
Net sales 12.67K 10.97K 10.38K 9.39K 17.63K 1.22M 17.76K 124K 47.64K 616K 47.59K 46.53K 1.97M 18.28K 15.83K 14.97K 13.55K 25.44K 1.75M 25.63K 179K 68.73K 889K 68.66K 67.14K 2.84M
Net income -899K -779K -736K -667K -1.25M -86.25M -1.26M -8.79M -3.38M -43.73M -3.38M -3.3M -139M -1.56M -1.35M -1.28M -1.16M -2.17M -149M -2.18M -15.23M -5.86M -75.77M -5.85M -5.72M -242M
Net Debt 206K 178K 168K 152K 286K 19.72M 288K 2.01M 773K 10M 772K 755K 31.9M 226K 196K 185K 168K 315K 21.68M 317K 2.21M 850K 10.99M 849K 830K 35.05M
Logo BioAdaptives, Inc.
BioAdaptives, Inc. operates in the health and wellness industry. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.
Employees
1
Date Price Change Volume
26-09-15 US$0.001500 0.00% 4,194,362
26-09-14 US$0.001500 -6.25% 14,012,689
26-09-11 US$0.001600 +14.29% 24,472,562
26-09-10 US$0.001400 +7.69% 28,283,887
26-09-09 US$0.001300 +8.33% 5,880,561
  1. Stock Market
  2. Stocks
  3. BDPT Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!